This is the first indication for pembrolizumab (Keytruda, Merck) in advanced renal cell carcinoma.
In rare cases, patients with HIV can experience a paradoxical response to antiretroviral therapy known as extreme immune decline.
Top news of the day from across the health care landscape.
This approval marks the first generic naloxone nasal spray for use in a community setting by an individual without medical training.
Sobetirome was shown to stimulate myelination in mice without the severe adverse effects commonly associated with thyroid hormone therapy for multiple sclerosis.
Top news of the week from Specialty Pharmacy Times.
Top news of the day from across the health care landscape.

Most Popular

Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.